Premium
Somerset Indus Capital Partners, a healthcare-focused private equity firm, has closed its sixth investment from its second fund by acquiring a minority stake in a company that makes active pharmaceutical ingredients. The PE firm, which counts companies such as Krsnaa Diagnostics, Hexagon Nutrition, Sterling Hospitals, and EMIL in its portfolio, has invested ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
